PanPath B.V. is currently extending its product line with novel FISH assays such as: gene amplifications (i.e. MDM2, EFGR), genetic rearrangements (i.e. RET, PLAG1), chromosomal imbalance (i.e. 3pter/3qter), various microdeletion syndrome assays (i.e. X-linked Kallmann, DiGeorge II), chromosomal enumeration probes (CEPs) and various locus-specific identifiers (LSIs).